Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed. This is a minor maintenance update that does not change study information.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedNew revision tag v3.4.2 appears and the site-wide funding notice was removed; no trial data or user actions were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operations. Updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check60 days agoChange DetectedAdded a glossary toggle and updated metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), while removing earlier labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No study content or user-facing information appears to be changed.SummaryDifference0.0%

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.